HEATHER KEEFE: Open Payments
NPI 1114567096 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 41 payments from 10 companies in 2025. Trend: 2023 $2,413 · 2024 $386 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $287 |
| Sumitomo Pharma America, Inc. | 12 | $214 |
| MILLICENT US INC | 4 | $75 |
| Organon LLC | 3 | $67 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $49 |
| Sage Therapeutics, LLC | 2 | $37 |
| Exeltis, USA Inc. | 2 | $30 |
| American Regent | 1 | $26 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $13 |
Products named: Veozah, MYFEMBREE, NEXPLANON, FEMLYV, ZURZUVAE, FEMRING, SLYND, INJECTAFER.
Industry payments across TX — which companies pay providers there.
